Listen Now

Take our post-test to claim CME credits.To read a companion newsletter click here.Why do PWID — people who inject drugs — continue as an uncontrolled source of HIV infection? Where are the missed opportunities for increased screening in this population? What barriers have been identified and what strategies can successfully overcome them? Which harm reduction initiatives have been proved effective, and can they be cost-effectively replicated? In this eHIV Review podcast, Dr. Josh Barocas from the Boston University School of Medicine and Boston Medical Center, and Dr. Raagini Jawa, an infectious disease and addiction medicine fellow at Boston Medical Center, provide a clinical perspective on these important questions.  See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits.To read a companion newsletter click here.Both the on-going syphilis and HIV epidemics are highly concentrated among men who have sex with men. While PrEP has been proven to reduce HIV transmission, it is not designed to prevent sexually transmitted infections like gonorrhea, syphilis, and chlamydia. What does the evidence say about reducing STI risk in MSM, and how can it be most effectively applied in practice? In this podcast, Dr. Matthew Spinelli — Assistant Professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital — takes us to the clinic to explain what providers can do to help their patients avoid acquiring and transmitting STIs. See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits. To read a companion newsletter click here.Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.  In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania takes us to the clinic to explain the pros and cons of the currently available HIV tests and explains which are best to use in particular clinical circumstances. See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits. To read a companion newsletter click here.In the US, nearly half of all people living with HIV are now aged 50 years or older. Their health care providers face new challenges in managing the effects of aging in their patients. In this eHIV Review podcast, Dr. Maile Young Karris from the University of California San Diego provides clinical insight into HIV and aging. See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits. To read a companion newsletter click here.In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers? In this issue, Dr. Rachel Scott, Scientific Director of Women's Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers. See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits. To read a companion newsletter click here.People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health?In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population. See acast.com/privacy for privacy and opt-out information.

Take our post-test to claim CME credits.To read a companion newsletter click here.In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 12“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U” from the clinical perspective, and models how it can help promote patient safety. Take our post-test to claim CME credits. To read a companion newsletter click here The post “U=U” — Clinical Considerations appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 10In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness. Take our post-test to claim CME credits. To read a companion newsletter click here The post Clinical Aspects of Improving ART Adherence appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 8While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents. Take our post-test to claim CME credits. To read a companion newsletter click here The post Clinical Perspective: New AEs from Newer ART appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 6.Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups.In this issue, two of the directors from Boston’s Health Care for the Homeless Program, Dr. Jennifer Brody, Director of HIV Services and ANP Marguerite Beiser, Director of HCV Services, discuss the clinical aspects of addressing these challenges.Take our post-test to claim CME credits.To read a companion newsletter click here.The post Clinical Challenges of Engaging PWID and MSM in HIV Care appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 4.The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans.In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic complications to help improve outcomes and quality of life in patients living with HIV.Take our post-test to claim CME credits.To read a companion newsletter click here.The post In the Clinic: ART and Metabolic Effects appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 4, Issue 2.To read a companion newsletter click here.The post New ART Agents: A Clinical Perspective appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 3, Issue 8.In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents.Take our post-test to claim CME credits.To read a companion newsletter click here.The post In The Clinic: Improving Outcomes in At-Risk Populations appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 3, Issue 6.In this podcast about ART, Dr. Rachel Simmons from Boston University School of Medicine discusses recent research that may improve clinicians' ability to more effectively and more safely manage their patients with HIV infection.Take our post-test to claim CME credits.To read a companion newsletter click here.The post New Advances in ART appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 3, Issue 4.In this podcast, Dr. Douglas Krakower discusses pre-exposure prophylaxis and addresses provider and patient barriers to PrEP.Take our post-test to claim CME credits.To read a companion newsletter click here.The post Pre-Exposure Prophylaxis: Addressing Provider and Patient Barriers appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 3, Issue 2.In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common comorbid diseases, and potential drug-drug interactions between antiretroviral agents and common over-the-counter medications.Take our post-test to claim CME credits.To read a companion newsletter click here.The post HIV: Management of Concomitant Conditions appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 12.Geetanjali Chander, MD, MPH, Associate Professor of Medicine covers the important topic of HIV and Alcohol in the format of case-study scenarios for the clinical practice.The post HIV and Alcohol appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 10.Shobha Swaminathan, MD, Assistant Professor of Medicine in the Divisions of Infectious Diseases at Rutgers New Jersey Medical School, covers the important topic of Current Issues in HIV/HCV Coinfection.The post Current Issues in HIV/HCV Coinfection appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.

Volume 2, Issue 8.Thomas Metkus, MD, Fellow in cardiovascular medicine, covers the important topic of HIV-Associated Cardiovascular Disease in the format of case-study scenarios for the clinical practice.The post HIV-Associated Cardiovascular Disease: An Update appeared first on DKBmed Radio. See acast.com/privacy for privacy and opt-out information.